Medical devices, healthcare technology and the business of care
510(k) clearance · K261800

Helo Max Thrombectomy System (HEL2090)

Endovascular Engineering · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK261800

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the Helo Max Thrombectomy System (HEL2090) on September 3, 2026, under 510(k) number K261800. The applicant is Endovascular Engineering of Menlo Park, California, and the device falls under 21 CFR 870.5150 (Embolectomy Catheter), Class II, product codes QEW and KRA, in the cardiovascular specialty. SESE is a clearance, not a PMA approval. The submission is a traditional 510(k) not reviewed by a third party, and the public record lists no combination product status and no authorized predetermined change control plan.

The reviewed item is a larger-diameter configuration of the Helo Thrombectomy System, cited as primary predicate K252956, with the Inari/Stryker FlowTriever Retrieval/Aspiration System (K211013) as reference predicate. The summary describes a 20F aspiration catheter introduced through a 20 or 22 Fr sheath that expands to 11 mm distally, with an integrated handle and a separately packaged 14F dilator. Stated indications cover non-surgical removal of emboli and thrombi from pulmonary arteries and venous vasculature. Bench testing and ethylene oxide sterilization validation are summarized; clinical outcome data and the basis for the predicate comparison are not detailed in the excerpts provided.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261800
Regulatory pathway
510(k) premarket notification
Product code
QEW
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.

Product code
QEW
FDA device class
2

FDA decision timeline

  1. K261800 received

    Application receipt date recorded by FDA.

  2. K261800 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEW

Product / regulatory recordCompanyPathwayDecision dateSource
Penumbra Inc.510(k) clearanceOct 15, 2026FDA
Inari Medical, Inc.510(k) clearanceSep 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Endovascular Engineering

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Menlo Park, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records